Diagnosis and management of the antiphospholipid syndrome
Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory diagnosis of APLA depends upon the detection of a lupus anticoagulant, which prolongs phospholipid-dependent anticoagulation tests, and/or anticardiolipin (aCL) and anti- β2-glycoprotein-1 (β2GPI) antibodies. APLA are primarily directed toward phospholipid binding proteins. Pathophysiologic mechanisms underlying thrombosis and pregnancy loss in APS include APLA induced cellular activation, inhibition of natural anticoagulant and fibrinolytic systems, and complement activation, among others.
Source: Blood Reviews - Category: Hematology Authors: Shruti Chaturvedi, Keith R. McCrae Tags: Review Source Type: research
More News: Antiphospholipid Syndrome | Hematology | Hughes Syndrome | Laboratory Medicine | Lupus | Pregnancy | Thrombosis